on August 9, 2023, the first course of digital medical accelerator sponsored by yuanyi capital, with chang development and Zhongguancun life science park as the guiding units, was successfully completed in Beijing.

the theme of this course is "the road to digital health care AI". Li yang, head of yuanyi digital health care accelerator, is the host. yang ruirong, partner of yuanyi capital, and Mao xinsheng, founder and chairman of digital health care technology, are the mentors. more than 20 students from all over the country participate in the course to explore the path of digital health care entrepreneurship. hopes to bring enlightenment to entrepreneurs of digital health care, accelerate the promotion of medical industry-university-research innovation.

in order to gain a deeper understanding of the development process of shukun science and technology, the accelerator course students arrived at shukun science and technology headquarters in beijing for a visit. Many students have conducted in-depth and simple communication with relevant personnel of Shukun Technology, trying to find the answer from the development path of this artificial intelligence head company.

Opening remarks

before the formal start of the course, yuanyi capital partner yang ruirong took the lead in delivering a speech. he said: "although the medical industry is impacted and challenged by various factors, from the perspective of social development process, the iteration from informatization to intelligence is inevitable. When the market crosses the economic downturn cycle, enterprises with intelligence as their core competence will rise again and dominate the evolutionary trend of the next generation of science and technology. Therefore, Yuanyi hopes to use the curriculum model to link successful entrepreneurs for practitioners and entrepreneurs in the medical industry, help everyone to give directions and reduce the cost of trial and error on the way to start a business."

Big coffee share

Later, Mao Xinsheng, founder and chairman of Kun Technology shared his entrepreneurial experience. He believed that in the preparation stage of entrepreneurship, attention should be paid to the initial heart and environment. The former can provide motivation for enterprises in entrepreneurship, while the latter can transform motivation into benefits. Specifically, entrepreneurs of digital health care should look for the contradictions in society and make it their mission to solve them; when solving problems, they should pay attention to whether there is a demand.

Taking Kun Technology as an example, we can see that the aging and declining birthrate in China are becoming more and more serious, and the lack of doctors is becoming more and more obvious. In this situation, the number of Kun technology introduced 'intelligence' this productivity.

while in the stage of solution building, mao xinsheng regards the word "innovation" as something that every start-up digital medical enterprise must insist on. he said in the course: kun technology chose the extremely difficult AI cardiovascular track at the beginning of its business. This track has nothing readily available, lacks public datasets for training, and lacks relevant academic research to support it. But we firmly believe in the value of AI in the cardiovascular field, step by step to promote related research new, step by step to build data sets.

in the end, we have created products that are close to clinical needs, such as AI products for cardiovascular, cerebrovascular and stroke, not only building barriers in technology, but also catching up in market access, taking the lead in the exploration of AI commercialization.

In addition, Mao Xinsheng also shared the experience of "artificial intelligence medical device product research and development and registration certificate" in the course. At present, Kun Science and Technology has both NMPA Class III and MDR CE certification in the three key areas of heart, brain and chest, and is the first to obtain NMPA Class III, EU MDR CE certification and US FDA certification in the field of cerebrovascular diseases. Kun Technology's digital doctor products have been used in nearly 3000 medical and health institutions nationwide with high stickiness, including more than 90% of the top 100 hospitals and 80% of the target public 3A hospitals.

Mentor Dialogue

In the subsequent mentor dialogue, Yang Ruirong raised a number of core issues in the field of medical artificial intelligence to Mao Xinsheng. When asked about the management experience of Sukun Technology, Mao Xinsheng said that in the early stage of starting a business, he should do more hands-on, feel every link and be familiar with the needs; and after the company matures, it should carry out standardized management to make the company operate more stably. Go down.

at the end of the course, many participants actively participated in the question-and-answer session of the tutor. they had several rounds of communication with the two tutors and further discussed such issues as "the development prospect of medical artificial intelligence", "how to manage the research and development team and the business team" and "how to view the fever of medical large models.

the successful holding of the first course of yuanyi digital medical accelerator has effectively promoted the sharing of successful entrepreneurial experiences in digital medical treatment and solved many doubts in the entrepreneurial journey of entrepreneurs. In future courses, Yuanyi will invite more top instructors to answer questions in the process of digital medical entrepreneurship.

First Session Instructor

Mao Xinsheng: founder and chairman of the board of directors of Shukun Technology. A well-known technology leader in the industry, with more than 20 years of R & D and management experience in China and the United States in the information technology industry, and has led a global R & D team of more than 7000 people. Graduated from Peking University in 1997, his main work experience includes chief technology officer of IBM China R & D Center, President of IBM Innovation Engineering Institute and member of IBM Global Strategy Committee. In 2017, he founded and served as chairman of the board of the company, with original and leading artificial intelligence technology, to promote the digitization and intelligence of the healthcare industry, its artificial intelligence products have been clinically applied in thousands of hospitals.

Yang Ruirong: Mr. Yang Ruirong is a partner of Yuanyi Capital, and he is committed to the innovative investment and industry construction of China's digital medical industry together with the team. Previously, he worked in Northern Lights Venture Capital and Lanxin Asia, and invested in many outstanding companies in the fields of healthcare, consumption, and technology. The representative projects led by Mr. Yang Ruirong include: Sukun Technology, Mixin Health, Xunshi Technology, Leno Medical, Baden Medical, Credible(ASX:CRD), Zhongke Chuangda (SZ:300496), Huada Gene (SZ:300676), Burning Stone Medicine (NASDAQ: BNR), Annoyoda, Yirui Optoelectronics (SH:688301), etc. Prior to entering the venture capital industry, he worked in the State Department of Commerce and was a diplomat at the Consulate General in Houston.